Teladoc Health Inc
TDOC7.890USD
+0.990+14.35%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
1.38BMarket Cap
LossP/E TTM
More Details of Teladoc Health Inc Company
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 35,000 licensed clinicians, leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
Company Info
Ticker SymbolTDOC
Company nameTeladoc Health Inc
IPO dateJul 01, 2015
Founded at2008
CEOMr. Charles (Chuck) Divita, III
Number of employees5500
Security typeOrdinary Share
Fiscal year-endJul 01
Address155 E 44Th Street
CityNEW YORK
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code10017
Phone12036352002
Websitehttps://www.teladochealth.com/
Ticker SymbolTDOC
IPO dateJul 01, 2015
Founded at2008
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Dr. Mark Douglas Smith, M.D.
Dr. Mark Douglas Smith, M.D.
Independent Director
Independent Director
8.36K
--
Mr. David B. Snow, Jr.
Mr. David B. Snow, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. J. Eric Evans
Mr. J. Eric Evans
Independent Director
Independent Director
--
--
Mr. Thomas G. Mckinley
Mr. Thomas G. Mckinley
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Charles (Chuck) Divita, III
Mr. Charles (Chuck) Divita, III
Chief Executive Officer, Director
Chief Executive Officer, Director
156.64K
--
Ms. Mala Murthy
Ms. Mala Murthy
Chief Financial Officer
Chief Financial Officer
132.44K
-9.47%
Mr. Adam C. Vandervoort, J.D.
Mr. Adam C. Vandervoort, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
69.77K
-7.68%
Ms. Kelly Bliss
Ms. Kelly Bliss
President, U.S. Group Health
President, U.S. Group Health
50.27K
-8.47%
Ms. Sandra L. Fenwick
Ms. Sandra L. Fenwick
Independent Director
Independent Director
40.43K
--
Mr. David L. Shedlarz
Mr. David L. Shedlarz
Independent Director
Independent Director
32.28K
+117.92%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
By BusinessUSD
Name
Revenue
Proportion
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
By RegionUSD
Name
Revenue
Proportion
United States
2.16B
84.06%
International
409.62M
15.94%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Access Fees Revenue
2.22B
86.21%
Other
354.35M
13.79%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.19%
BlackRock Institutional Trust Company, N.A.
7.28%
Renaissance Technologies LLC
3.73%
Point72 Asset Management, L.P.
3.71%
Two Sigma Investments, LP
3.02%
Other
71.06%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
32.79%
Hedge Fund
17.95%
Investment Advisor
17.80%
Research Firm
4.68%
Individual Investor
1.09%
Bank and Trust
0.64%
Pension Fund
0.48%
Sovereign Wealth Fund
0.10%
Venture Capital
0.04%
Other
24.43%
Institutional Shareholding
Updated: Tue, Mar 4
Updated: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
1023
133.05M
75.84%
-33.56M
2024Q4
1063
134.61M
77.51%
-37.55M
2024Q3
1133
134.94M
78.45%
-32.89M
2024Q2
1195
142.47M
83.22%
-14.73M
2024Q1
1317
130.90M
77.27%
-19.41M
2023Q4
1432
129.36M
77.56%
-18.52M
2023Q3
1538
125.63M
75.92%
-38.92M
2023Q2
1640
129.13M
78.35%
-41.97M
2023Q1
1761
137.47M
83.88%
-27.34M
2022Q4
1860
135.36M
83.16%
-23.04M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
18.43M
10.61%
+1.03M
+5.92%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
13.67M
7.87%
-227.05K
-1.63%
Dec 31, 2024
Renaissance Technologies LLC
5.67M
3.27%
+763.26K
+15.54%
Dec 31, 2024
Point72 Asset Management, L.P.
11.18M
6.44%
+2.81M
+33.63%
Dec 31, 2024
Two Sigma Investments, LP
4.28M
2.46%
+3.56M
+492.73%
Dec 31, 2024
Dimensional Fund Advisors, L.P.
3.53M
2.03%
+8.89K
+0.25%
Dec 31, 2024
State Street Global Advisors (US)
5.08M
2.92%
+446.18K
+9.63%
Dec 31, 2024
Geode Capital Management, L.L.C.
3.95M
2.27%
+22.66K
+0.58%
Dec 31, 2024
Maple Rock Capital Partners, Inc.
3.56M
2.05%
+2.33M
+189.51%
Dec 31, 2024
Wellington Management Company, LLP
3.14M
1.81%
-60.80K
-1.90%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Counterpoint Quantitative Equity ETF
1.88%
Global X HealthTech ETF
1.35%
Fidelity Digital Health ETF
1.12%
First Trust Indxx Metaverse ETF
0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.59%
Principal U.S. Small-Cap ETF
0.45%
Langar Global HealthTech ETF
0.45%
SPDR S&P Kensho New Economies Composite ETF
0.24%
iShares U.S. Healthcare Providers ETF
0.21%
Avantis US Small Cap Equity ETF
0.14%
View more
Counterpoint Quantitative Equity ETF
Proportion1.88%
Global X HealthTech ETF
Proportion1.35%
Fidelity Digital Health ETF
Proportion1.12%
First Trust Indxx Metaverse ETF
Proportion0.98%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.59%
Principal U.S. Small-Cap ETF
Proportion0.45%
Langar Global HealthTech ETF
Proportion0.45%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.24%
iShares U.S. Healthcare Providers ETF
Proportion0.21%
Avantis US Small Cap Equity ETF
Proportion0.14%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
